Does White Label Rx charge a software fee on top of drug cost?

Two pricing structures with the same headline drug rate can cost very differently once the software layer is included. A recurring monthly platform fee is fixed regardless of how much you order, so it is cheap per vial at high volume and expensive per vial at low volume. A per-transaction or percentage fee scales with spend. A fee folded into the drug rate is invisible but real. To compare White Label Rx fairly, ask whether there is a separate software, subscription, or account fee; whether it is monthly, per order, or percentage-based; and whether it changes at volume tiers. Then compute total cost of ownership over a representative month, not just per-vial drug cost.

This is also where a low advertised drug rate can mislead. If White Label Rx quotes an attractive per-vial number but pairs it with a recurring platform fee, your effective cost per vial is higher than the quote suggests — especially while your volume is still ramping. The only honest comparison adds the software layer back in.

Fizy Health structures the two layers to be legible: drug cost passes through and is shown as resolved per-vial 503A cost on each catalog and cart line before checkout, and the platform's economics are a single facilitation fee disclosed separately at payment. There is no hidden software charge folded into the drug rate, so total cost of ownership is the visible drug cost plus the named fee — a number you can compute before you order.

That makes a like-for-like comparison straightforward. Add any White Label Rx software or platform fee to its quoted drug rate over a representative month, then set that total against the visible per-vial cost plus disclosed facilitation fee for the same SKUs and volume. Comparing total-to-total — not drug-rate-to-drug-rate — is the only way to see which model actually costs less to run.